MEDICAL SCIENCES. For the article “Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea,” by Hajime Kubo, Renhai Cao, Ebba Bräkenhielm, Taija Mäkinen, Yihai Cao, and Kari Alitalo, which appeared in issue 13, June 25, 2002, of Proc. Natl. Acad. Sci. USA (99, 8868–8873; First Published June 17, 2002; 10.1073/pnas.062040199), the authors note that the indication of black and white bars was inverted in the legend of Fig. 3. The legend should have read, “Black bars, angiogenic score; white bars, lymphangiogenic score.” The figure and its corrected legend appear below.
Fig. 3.
Quantification of the corneal angiogenesis and lymphangiogenesis. (a) Quantification of the angiogenesis and lymphangiogenesis induced by VEGF, VEGF-C, and FGF-2 (n = 3 each) analyzed by immunostaining as described in Materials and Methods.(b) Quantification of the angiogenesis and lymphangiogenesis in FGF-2-implanted corneas treated with anti-VEGFR3 (α-VEGFR-3) in comparison with the corneas of animals treated with nonblocking anti-VEGFR-2 control antibodies (Control). Black bars, angiogenic score; white bars, lymphangiogenic score. The graphs represent mean values ± SEM.